Office of the Director, National Institutes of Health; Amended Notice-Request for Public Comment, 14705-14706 [05-5671]

Download as PDF Federal Register / Vol. 70, No. 55 / Wednesday, March 23, 2005 / Notices Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Jury’s Washington Hotel, 1500 New Hampshire Avenue, NW., Washington, DC 20036. Contact Person: Gayle M. Boyd, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3028–D, MSC 7759, Bethesda, MD 20892, 301–451– 9956. gboyd@mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel, Skeletal Biological Pilot/Feasibility, AREA and Small Grant Group 2. Date: April 6, 2005. Time: 8 a.m. to 8 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Daniel F. McDonald, PhD, Chief, Renal and Urological Sciences IRG, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4214, MSC 7814, Bethesda, MD 20892. (301) 435–1215, mcdonald@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Preadolescent Exposure to Tobacco Smoke. Date: April 6, 2005. Time: 9:30 a.m. to 10:30 a.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Gayle M. Boyd, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3028–D, MSC 7759, Bethesda, MD 20892, 301–451– 9956. gboyd@mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Skin Mutagenesis. Date: April 7, 2005. Time: 2 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Syed M. Quadri, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6210, MSC 7804, Bethesda, MD 20892, (301) 435– 1211. quadris@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Skeletal Biology Pilot/Feasibility, AREA and Small Grant Group 1. Date: April 8, 2005. Time: 8 a.m. to 8 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). VerDate jul<14>2003 19:44 Mar 22, 2005 Jkt 205001 Contact Person: Daniel F. McDonald, PhD, Chief, Renal and Urological Sciences IRG, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4214, MSC 7814, Bethesda, MD 20892, (301) 435–1215,mcdonald@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Disease Recovery. Date: April 8, 2005. Time: 2 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Karen Lechter, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3128, MSC 7759, Bethesda, MD 20892, (301) 496– 0726, lechterk@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Arial Remodeling. Date: April 18, 2005. Time: 1 p.m. to 2 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Ai-Ping Zou, PhD, MD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4118, MSC 7814, Bethesda, MD 20892, (301) 435– 1777, zouai@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, 3D Morphometry. Date: April 19, 2005. Time: 2:30 p.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Russell T. Dowell, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4128, MSC 7814, Bethesda, MD 20892, (301) 435– 1850, dowellr@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Renal Related Sciences. Date: April 19, 2005. Time: 12 p.m. to 1:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: M. Chris Langub, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4112, MSC 7814, Bethesda, MD 20892, (301) 496– 8551, langubm@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Renal and Urology Member Conflict. Date: April 22, 2005. Time: 2 p.m. to 4 p.m. PO 00000 Frm 00071 Fmt 4703 Sfmt 4703 14705 Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Shirley Hilden, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4218, MSC 7814, Bethesda, MD 20892, (301) 435– 1198, hildens@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Fatty Acids and Colon Tumorigenesis. Date: April 25, 2005. Time: 11 a.m. to 12 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Angela Y. Ng, PhD, MBA, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6200, MSC 7804, (for courier delivery, use MD 20817), Bethesda, MD 20892, 301–435–1715, nga@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Small Business Orthopedic Medicine Applications. Date: April 26–27, 2005. Time: 6 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: Wyndham Washington, DC, 1400 M Street, NW., Washington, DC 20005. Contact Person: Richard J. Bartlett, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4110, MSC 7814, Bethesda, MD 20892, 301–435– 6809, bartletr@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: March 16, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–5672 Filed 3–22–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director, National Institutes of Health; Amended Notice— Request for Public Comment Notice is hereby given of a change in the submission date of public comments. Comments will be accepted until April 10, 2005, instead of March 31, 2005, as published in the Federal Register on March 9, 2005, 70 FR 4568. The Secretary’s Advisory Committee on Xenotransplantation (SACX) is E:\FR\FM\23MRN1.SGM 23MRN1 14706 Federal Register / Vol. 70, No. 55 / Wednesday, March 23, 2005 / Notices requesting public comment on two draft reports on xenotransplantation. One is on the state of the science of xenotransplantation and the other is on informed consent issued in clinical trials involving xenotransplantation. Before the reports are finalized and transmitted to the Secretary, the SACX is requesting comments on the draft reports from members of the public. All public comments received will be considered in finalizing the reports. Comments should be submitted by March 31, 2005 [amended to April 10, 2005]. Received comments will be available for public inspection at the NIH Office of Biotechnology Activities, Monday through Friday between the hours of 8:30 a.m. and 5 p.m., at the contact address noted below. Information: The Secretary’s Advisory Committee on Xenotransplantation, Department of Health and Human Services, considers the scientific, medical, social, and ethical issues and the public health concerns raised by xenotransplantation and makes recommendations to the Secretary on policy and procedures. The Committee’s charges include advising on the current state of knowledge regarding xenotransplantation and on the potential for transmission of infectious diseases as a consequence of xenotransplantation; and deliberating on medical, public health, ethical, legal and socioeconomic issues, including international policies and developments that are relevant to xenotransplantation. Overview of Drafts: The state of the science report addresses the scientific challenges in xenotransplantation, the infectious disease risks associated with xenotransplantation, public health concerns associated with xenotourism, knowledge gaps and resource limitations, and alternative strategies to xenotransplantation. The report also proposes a series of recommendations regarding these issues. The report on informed consent issues in clinical research involving xenotransplantation addresses the ethical foundations and functions of informed consent, components of informed consent, the informed consent process, informed consent forms, and special issues raised by xenotransplantation. The report proposes a series of recommendations regarding informed consent in xenotransplantation research. A full draft reports are available electronically at https:// www4.od.nih.gov/oba/Sacx.htm. A paper or electronic copy can also be requested by calling the NIH Office of Biotechnology Activities at (301) 496– VerDate jul<14>2003 17:54 Mar 22, 2005 Jkt 205001 9838 or by e-mailing Marcy Groesch at groeschm@od.nih.gov. Contact Person: March Groesch, Executive Director, Secretary’s Advisory Committee on Xenotransplantation, Office of Biotechnology Activities, Rockledge I, Room 750, Bethesda, MD 20892, (301) 496–9838. (Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantages Backgrounds; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program, National Institutes of Health, HHS) Dated: March 16, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–5671 Filed 3–22–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HOMELAND SECURITY Citizenship and Immigration Services Agency Information Collection Activities: Extension of a Currently Approved Information Collection; Comments Request 30-Day Notice of Information Collection Under Review: Application for Status as Temporary Resident under Section 245A of the Immigration and Nationality Act, Form I–687. ACTION: The Department of Homeland Security, U.S. Citizenship and Immigration Services (USCIS) has submitted the following information collection request to the Office of Management and Budget (OMB) for review and clearance in accordance with the Paperwork Reduction Act of 1995. The information collection was previously published in the Federal Register on March 24, 2004 at 69 FR 13865, allowed for a 60-day public comment period. The USCIS did not receive any comments on this information collection. The purpose of this notice is to allow an additional 30 days for public comments. Comments are encouraged and will be accepted until April 22, 2005. This process is conducted in accordance with 5 CFR 1320.10. Written comments and suggestions from the public and affected agencies concerning the collection of information PO 00000 Frm 00072 Fmt 4703 Sfmt 4703 should address one or more of the following points: (1) Evaluate whether the collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (2) Evaluate the accuracy of the agency’s estimate of the burden of the collection of information, including the validity of the methodology and assumptions used; (3) Enhance the quality, utility, and clarity of the information to be collected; and (4) Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques, or other forms of information technology, e.g., permitting electronic submission of responses. Overview of this information collection: (1) Type of Information Collection: Extension of a currently approved collection. (2) Title of the Form/Collection: Application for Status as Temporary Resident under Section 245A of the Immigration and Nationality Act. (3) Agency Form Number, if Any, and the Applicable Component of the Department of Homeland Security Sponsoring the Collection: Form I–687. U.S. Citizenship and Immigration Services. (4) Affected Public Who Will be Asked or Required to Respond, as Well as a Brief Abstract: Primary: Individuals and Households. The collection of information on Form I–687 is required to verify the applicant’s eligibility for temporary status, and if the applicant is deemed eligible, to grant him or her the benefit sought. (5) An Estimate of the Total Number of Respondents and the Amount of Time Estimated for an Average Respondent to Respond: 100,000 responses at 1 hour and 10 minutes (1.16 hours) per response. (6) An Estimate of the Total Public Burden (in Hours) Associated With the Collection: 116,000 annual burden hours. If you have comments, suggestions, or need a copy of the information collection instrument, please contact Richard A. Sloan, Director, Regulatory Management Division, Department of Homeland Security, 111 Massachusetts Avenue, NW., Washington, DC 20529; 202–272–8377. E:\FR\FM\23MRN1.SGM 23MRN1

Agencies

[Federal Register Volume 70, Number 55 (Wednesday, March 23, 2005)]
[Notices]
[Pages 14705-14706]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-5671]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Amended 
Notice--Request for Public Comment

    Notice is hereby given of a change in the submission date of public 
comments. Comments will be accepted until April 10, 2005, instead of 
March 31, 2005, as published in the Federal Register on March 9, 2005, 
70 FR 4568.
    The Secretary's Advisory Committee on Xenotransplantation (SACX) is

[[Page 14706]]

requesting public comment on two draft reports on xenotransplantation. 
One is on the state of the science of xenotransplantation and the other 
is on informed consent issued in clinical trials involving 
xenotransplantation.
    Before the reports are finalized and transmitted to the Secretary, 
the SACX is requesting comments on the draft reports from members of 
the public. All public comments received will be considered in 
finalizing the reports. Comments should be submitted by March 31, 2005 
[amended to April 10, 2005]. Received comments will be available for 
public inspection at the NIH Office of Biotechnology Activities, Monday 
through Friday between the hours of 8:30 a.m. and 5 p.m., at the 
contact address noted below.
    Information: The Secretary's Advisory Committee on 
Xenotransplantation, Department of Health and Human Services, considers 
the scientific, medical, social, and ethical issues and the public 
health concerns raised by xenotransplantation and makes recommendations 
to the Secretary on policy and procedures. The Committee's charges 
include advising on the current state of knowledge regarding 
xenotransplantation and on the potential for transmission of infectious 
diseases as a consequence of xenotransplantation; and deliberating on 
medical, public health, ethical, legal and socioeconomic issues, 
including international policies and developments that are relevant to 
xenotransplantation.
    Overview of Drafts: The state of the science report addresses the 
scientific challenges in xenotransplantation, the infectious disease 
risks associated with xenotransplantation, public health concerns 
associated with xenotourism, knowledge gaps and resource limitations, 
and alternative strategies to xenotransplantation. The report also 
proposes a series of recommendations regarding these issues.
    The report on informed consent issues in clinical research 
involving xenotransplantation addresses the ethical foundations and 
functions of informed consent, components of informed consent, the 
informed consent process, informed consent forms, and special issues 
raised by xenotransplantation. The report proposes a series of 
recommendations regarding informed consent in xenotransplantation 
research.
    A full draft reports are available electronically at https://
www4.od.nih.gov/oba/Sacx.htm. A paper or electronic copy can also be 
requested by calling the NIH Office of Biotechnology Activities at 
(301) 496-9838 or by e-mailing Marcy Groesch at groeschm@od.nih.gov.
    Contact Person: March Groesch, Executive Director, Secretary's 
Advisory Committee on Xenotransplantation, Office of Biotechnology 
Activities, Rockledge I, Room 750, Bethesda, MD 20892, (301) 496-9838.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.187, Undergraduate 
Scholarship Program for Individuals from Disadvantages Backgrounds; 
93.22, Clinical Research Loan Repayment Program for Individuals from 
Disadvantaged Backgrounds; 93.232, Loan Repayment Program for 
Research Generally; 93.39, Academic Research Enhancement Award; 
93.936, NIH Acquired Immunodeficiency Syndrome Research Loan 
Repayment Program, National Institutes of Health, HHS)


    Dated: March 16, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-5671 Filed 3-22-05; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.